After retired race car star Michael Schumacher severely injured his head in a fall while skiing last month, doctors in France removed part of his skull to relieve dangerous swelling in his brain. How much their treatment will help in the long run is an open question.
U.K. biotechnology start-up Oxitec Ltd. wants to start U.S. tests of a new weapon in the war on dengue fever: genetically modifying mosquitoes that carry the disease so that their progeny self-destruct.
GlaxoSmithKline Plc’s experimental malaria vaccine safely reduced illness in African infants by more than half, a finding that’s a step toward its eventual use in preventing the deaths of as many as 800,000 children a year.
People in the U.K. are having sex into their 70s, though the average frequency for men and women of all ages has declined over the last decade, according to the National Survey of Sexual Attitudes and Lifestyles.
The financial catastrophe in Greece is damaging public health and wellbeing, according to six medical academics including Alexander Kentikelenis and David Stuckler of Cambridge University and Martin McKee of the London School of Hygiene and Tropical Medicine.
A type of intravenous solution made by Fresenius SE and B. Braun Holding GmbH that’s used to treat shock has a 10 percent higher risk of death than another treatment, an analysis by U.K. researchers found.